More recently, scRNA-seq studies have further refined the characterisation of this CD4+ T cell subset, including CD57 expression, in the context of both viral infection18, anti-tumour responses19, and autoimmunity (primary Sjogren’s syndrome)20. The gene discussed is CD4; the disease is neoplasm.